ApoAI deficiency results in marked reductions in plasma cholesterol but no alterations in amyloid-beta pathology in a mouse model of Alzheimer's disease-like cerebral amyloidosis. uri icon

authors

  • Fagan, Anne M
  • Paul, Steven M
  • David M. Holtzman, MD
  • Christopher, Erin
  • Taylor, Jennie W
  • Parsadanian, Maia
  • Spinner, Michael
  • Watson, Melanie
  • Fryer, John D
  • Wahrle, Suzanne
  • Bales, Kelly R

publication date

  • January 1, 2004